Skip to main content

Table 1 Characteristics of patients included in the study

From: Class-modeling analysis reveals T-cell homeostasis disturbances involved in loss of immune control in elite controllers

Characteristic Control group (n = 22) Case group (n = 14) p value
Age (years)a 40 [35, 48] 42 [39, 48] 0.58
Gender (% of males) 33 69 0.04
Follow-up maintaining EC status (years) 12 [10, 13] 9 [5, 12] 0.02
Time since HIV diagnosis (years) 19.3 [14.8, 24.1] 19.3 [9.6, 21.8] 0.62
CD4 count at the beginning of follow-up (cells/μL) 838 [646, 1097] 1047 [881, 1125] 0.06
CD4 count at the end of follow-up (cells/μL) 931 [675, 1147] 632 [443, 843] 0.01
CD4 slope (cells/μL per year) 8.9 [1.2, 19] -66 [− 113, −32] < 0.0001
CD4 count at the moment of the study (cells/μL) 889 [752, 1051] 886 [548, 1280] 0.87
Hepatitis C virus positive (%) 80 69 0.68
Patients with non-AIDS defining events during the follow-up period (%) 11 11 1
Number of HIV-RNA blips (pVL > 50 copies/mL) 2 [0, 2.3] 1 [0, 2.3] 0.43
  1. EC elite controller
  2. aData for continuous variables are given as median [interquartile range]